Annual Meeting

Sugar coating is, in fact, important

A 2022 annual meeting session on glycobiology
Valerie Weaver Steve Withers
By Valerie Weaver and Steve Withers
Oct. 7, 2021

Like people, whether they want to or not, cells need to interact with others around them. One way people interact is through the way they dress. Indeed, we often are judged by the clothes we wear. Cells are "clothed" in a specialised sugar layer known as the glycocalyx in which specific sugar structures are displayed on proteins and lipids. Based on this outer clothing layer, the cell is recognised by both friend and foe.

In this symposium, we will learn about new ways to identify, locate and quantitate the glycans present on different cells under specific conditions. We also will hear how we can dress cells for success through modification of their surface structures. In another section, we will learn how pathogens can recognize and invade cells through specific glycocalyx structures.

We also will hear several accounts of how cancer progression can be mediated through overexpression of glycans such as sialic acid and heparan. Apparently, as with people, inhibitions can be dampened by exuberance in cellular dressing. Learn about this and more at our symposium.

Keywords: glycosylation, glycocalyx, cellular interfaces, cancer, immunity, infection

Who should attend: anyone who is interested in understanding how cells function and interact with their environment through their surface glycan coat and anyone interested in cool new ways to modulate those interactions through carbohydrate chemistry and enzymology

Theme song (at least for the mucinophiles): "Born to Run" by Bruce Springsteen

This session is powered by interdisciplinary science with a sweet touch.

Talks

  • Nanoscale physical biology of the cellular glycocalyx — Matthew J. Paszek, Cornell University
  • MALDI imaging mass spectrometry mapping of the glycocalyx — Richard R. Drake, Medical University of South Carolina
  • Genetic and small molecule strategies to edit the glycocalyx — Sriram Neelamegham​, State University of New York at Buffalo
  • Enzymatic removal of cell surface antigens as a route towards universal O type blood and organs — Stephen Withers, University of British Columbia
  • Hypersialylation of tumor cells promotes pancreatic cancer progression — Susan Bellis, University of Alabama at Birmingham
  • Receptor N-glycosylation links metabolism with signaling — James Dennis, Lunenfeld Tanenbaum Research Institute
  • Modeling the mucinous glycocalyx to unravel receptor pattern recognition by influenza A viruses — Kamil GodulaUniversity of California, San Diego
  • Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function — Geert-Jan Boons, University of Georgia
  • The glycocalyx in tumor progression and metastasis — Valerie Weaver, University of California, San Francisco
  • The heparanase/syndecan-1 axis in cancer progression — Ralph D. Sanderson, University of Alabama at Birmingham
  • Reprogramming T cells to target glycans and overcome glycan-mediated immunosuppression for cancer therapy — Avery Posey, University of Pennsylvania
  • Orchestrated intragranular restructuring of mucins during secretory granule maturation — Kelly Ten Hagen, National Institute of Dental and Craniofacial Research

Learn more

Check out all ten thematic symposia planned for the 2022 ASBMB annual meeting:

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Valerie Weaver
Valerie Weaver

Valerie M. Weaver is the director of the Center for Bioengineering and Tissue Regeneration in the Department of Surgery at the University of California, San Francisco, and also a Canadian.

Steve Withers
Steve Withers

Steve Withers is a professor of chemistry and biochemistry at the University of British Columbia.

Featured jobs

from the ASBMB career center

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Building a better model for drug delivery across the blood–brain barrier
Journal News

Building a better model for drug delivery across the blood–brain barrier

May 19, 2026

Industry and academic scientists collaborated to develop a rat with humanized iron-transport receptors, enabling research into iron homeostasis and drugs that cross the brain’s barrier.

Fat synthesis enzyme crucial for milk fat and newborn growth
Journal News

Fat synthesis enzyme crucial for milk fat and newborn growth

May 14, 2026

Researchers found that a deficiency of the fatty acid synthesis enzyme stearoyl-CoA desaturase-1 reduced mammary gland function during lactation and caused low birth weight in newborns that were fed milk from enzyme-deficient glands.

Flipping lipids and slime molds
Interview

Flipping lipids and slime molds

May 12, 2026

A dull first job nearly pushed JBC associate editor Todd Graham out of science. Then a slime mold project changed his path. Now, he studies membrane biology and reflects on discovery, persistence and mentoring through uncertainty.

How smelling death alters worm behavior
News

How smelling death alters worm behavior

May 7, 2026

Researchers have found that the roundworm C. elegans can smell death, and it changes how the worms behave, reproduce and age.

A chance encounter with the lab
Profile

A chance encounter with the lab

May 5, 2026

Payton Stevens never planned to become a pancreatic cancer researcher. A temporary job set him on a path from rural Kentucky to leading research on Wnt signaling and metastasis, where he now pairs discovery with mentorship and science advocacy.

Light-activated small molecule could transform eye infection treatment
News

Light-activated small molecule could transform eye infection treatment

April 21, 2026

Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.